← Back to Patent Explorer
US4745177A Expired / Lapsed US ⏱️ 0.0 years remaining

Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them

Assignee: UCP Gen Pharma AG
•
Filing: 1986-11-13
•
Granted: 1988-05-17
•
Expires: 2006-11-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to desulfatohirudins, to the preparation thereof, to pharmaceutical compositions containing these compounds, and to the use thereof. The desulfatohirudins of this invention correspond to hirudin in biological activity and are therefore particularly useful for inhibiting blood clotting.

Inventors

  • 👤 Hans Fritz
  • 👤 Johannes Dodt
  • 👤 Ursula Seemuller
  • 👤 Ernst Fink

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 14:59
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/81; C07K14/815; A; A61; A61P; A61P7/00; A61P7/02; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/26

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 35 words
A desulfatohirudin of the formula I ##STR3## or of the formula II ##STR4## wherein the --Cys-- residues are linked in pairs by disulfide bridges in the same manner as in hirudin, or a salt thereof.
Claim 2
Dependent Claim 35 words
A desulfatohirudin of the formula I ##STR3## or of the formula II ##STR4## wherein the --Cys-- residues are linked in pairs by disulfide bridges in the same manner as in hirudin, or a salt thereof.
Claim 3
Dependent Claim 16 words
The desulfatohirudin according to claim 1 characterised by formula I, or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 16 words
The desulfatohirudin according to claim 1 characterised by formula II, or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 28 words
A pharmaceutical composition containing at least one desulfatohirudin according to claim 1, or a pharmacologicallly acceptable salt thereof, optionally together with at least one pharmaceutical carrier or excipient.

References Cited (Backward Citations)

US4668662A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-05-17 1991-11-16 1992-05-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-05-17 1995-11-16 1996-05-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-05-17 1999-11-16 2000-05-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag